Phase 3 study of tucatinib, trastuzumab, and modified FOLFOX6 as first-line treatment in HER2+metastatic colorectal cancer (MOUNTAINEER-03, trial in progress) Meeting Abstract
| Authors: | Fritsch, R.; Andre, T.; Bekaii-Saab, T.; Cercek, A.; Nakamura, Y.; Raghav, K.; Siena, S.; Strickler, J.; Van Cutsem, E.; Adelberg, D.; Ramos, J.; Yang, S.; Yoshino, T.; Tabernero, J. |
| Abstract Title: | Phase 3 study of tucatinib, trastuzumab, and modified FOLFOX6 as first-line treatment in HER2+metastatic colorectal cancer (MOUNTAINEER-03, trial in progress) |
| Meeting Title: | 6th Swiss Oncology and Hematology Congress (SOHC) |
| Journal Title: | Swiss Medical Weekly |
| Volume: | 153 |
| Issue: | Suppl. 274 |
| Meeting Dates: | 2023 Nov 22-24 |
| Meeting Location: | Basel, Switzerland |
| ISSN: | 1424-7860 |
| Publisher: | E M H Swiss Medical Publishers Ltd |
| Date Published: | 2023-11-01 |
| Start Page: | 70S |
| Language: | English |
| ACCESSION: | WOS:001104401500090 |
| PROVIDER: | wos |
| PUBMED: | 37984367 |
| DOI: | 10.57187/s.3469 |
| Notes: | Meeting Abstract: 196 -- Source: Wos |
